Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease
出版年份 2018 全文链接
标题
Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease
作者
关键词
-
出版物
Scientific Reports
Volume 8, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-03-15
DOI
10.1038/s41598-018-23277-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- An oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: Results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapy
- (2017) Einat Almon et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Bivalent Llama Single-Domain Antibody Fragments against Tumor Necrosis Factor Have Picomolar Potencies due to Intramolecular Interactions
- (2017) Els Beirnaert et al. Frontiers in Immunology
- Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases
- (2016) Bella Ungar et al. Clinical Gastroenterology and Hepatology
- Inflammatory Bowel Disease Provoked by Etanercept: Report of 443 Possible Cases Combined from an IBD Referral Center and the FDA
- (2016) Aoibhlinn O’Toole et al. DIGESTIVE DISEASES AND SCIENCES
- Effects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative Colitis
- (2016) Deborah S. Hartman et al. Journal of Crohns & Colitis
- AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial
- (2016) M. Scott Harris et al. Journal of Crohns & Colitis
- Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease
- (2016) Alon D. Levin et al. Journal of Crohns & Colitis
- Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases
- (2016) Ulrike Billmeier et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Proteolytic Cleavage and Loss of Function of Biologic Agents That Neutralize Tumor Necrosis Factor in the Mucosa of Patients With Inflammatory Bowel Disease
- (2015) Paolo Biancheri et al. GASTROENTEROLOGY
- From historical perspectives to modern therapy: a review of current and future biological treatments for Crohn’s disease
- (2015) Charles W. Randall et al. Therapeutic Advances in Gastroenterology
- A CD3-Specific Antibody Reduces Cytokine Production and Alters Phosphoprotein Profiles in Intestinal Tissues From Patients With Inflammatory Bowel Disease
- (2014) Anna Vossenkämper et al. GASTROENTEROLOGY
- Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α
- (2014) David J. Shealy et al. mAbs
- In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease
- (2014) Raja Atreya et al. NATURE MEDICINE
- Protease-resistant single-domain antibodies inhibit Campylobacter jejuni motility
- (2014) G. Hussack et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Nanobodies: Natural Single-Domain Antibodies
- (2013) Serge Muyldermans Annual Review of Biochemistry
- AVX-470
- (2013) Kailash C. Bhol et al. INFLAMMATORY BOWEL DISEASES
- Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease
- (2013) Ole Haagen Nielsen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dextran Sodium Sulphate Colitis Mouse Model: Traps and Tricks
- (2012) Martina Perše et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Quantitation of Affinity, Avidity, and Binding Kinetics of Protein Analytes with a Dynamically Switchable Biosurface
- (2012) Jelena Knezevic et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Oral tolerance to food protein
- (2012) O Pabst et al. Mucosal Immunology
- Antibodies Against Tumor Necrosis Factor (TNF) Induce T-Cell Apoptosis in Patients With Inflammatory Bowel Diseases via TNF Receptor 2 and Intestinal CD14+ Macrophages
- (2011) Raja Atreya et al. GASTROENTEROLOGY
- Engineered Single-Domain Antibodies with High Protease Resistance and Thermal Stability
- (2011) Greg Hussack et al. PLoS One
- Oral Administration of OKT3 Monoclonal Antibody to Human Subjects Induces a Dose-Dependent Immunologic Effect in T Cells and Dendritic Cells
- (2009) Yaron Ilan et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis
- (2009) K Vandenbroucke et al. Mucosal Immunology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started